$61.45
-1.35-2.16%
Last update: Nov 11, 10:04 AM
Bristol-Myers Squibb Co
BMYNYSE
Bristol-Myers Squibb rose 28.9% from $48.72 to $62.80, ahead of the S&P 500's +9.8%. Its worst day was Nov 14 (−4.1%), and its low came Nov 19 at $45.79.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Bristol-Myers Squibb closed at its lowest level of the year, 6.0% below where the year started.
−2.7% · S&P 500 +0.4%
EPS of $1.26 beat the $1.19 estimate on $12.5B revenue (est. $12.3B); FY revenue guidance of $46.0B–$47.5B against the $44.2B consensus.
Story events cover the past 12 months · Times ET
+3.3% · S&P 500 −1.2%
EPS of $1.58 beat the $1.43 estimate on $11.5B revenue (est. $10.9B); FY revenue guidance of $46.0B–$47.5B against the $47.1B consensus.
+5.2%, the year's best day · S&P 500 +1.0%
EPS of $2.04 beat the $1.61 estimate on $13.0B revenue (est. $11.7B); FY revenue guidance of $49.0B–$50.0B against the $47.3B consensus.
+2.8% · S&P 500 +1.7%
Bristol-Myers Squibb closed at its highest level of the year, 39.8% above where the year started.
+0.6% · S&P 500 +1.0%
Bristol-Myers Squibb shares rose 4.8%, while the S&P 500 rose 0.3%.
+4.8% · S&P 500 +0.3%
EPS of $1.35 beat the $1.24 estimate on $13.1B revenue (est. $12.7B); FY revenue guidance of $49.8B–$50.3B against the $49.9B consensus.
+1.4% · S&P 500 −0.4%
Where it ended: a close of $62.80 on Nov 10, 2026. Up next: Q4 2026 earnings on Feb 4, 2027 (EPS est. $1.51, revenue est. $12.7B).
As of the Nov 10, 2026 close
Replay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BMY and SPY from Benzinga historical bars. Not investment advice.
